Appointed Director and General Manager at Fojann Biopharmaceuticals limited in February 2025.
Holds a Ph.D. and completed postdoctoral research at the Institute of Intelligent Medicine, Fudan University. Possesses years of experience in precision medicine and knowledge bases, primarily engaged in research related to AI+Medicine, focusing on the construction of biomedical knowledge graphs and multimodal reasoning. Engaged in interdisciplinary research at the intersection of biomedicine and artificial intelligence, with extensive experience in biomedical big data integration and mining, the construction and reasoning of biomedical knowledge graphs, and personalized medicine. Participated in multiple national key R&D projects related to medical informatization.